Showing results (31-40 of 128) with videos related to
Sort By:
Pageof 13
HIV Medicine|July 30, 2021
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrelOwain Roberts, Hannah Kinvig, Andrew Owen, et al.Clinical Pharmacokinetics|August 22, 2018
Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent ChangesFelix Stader, Marco Siccardi, Manuel Battegay, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 30, 2010
Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compoundsLaura Else, Victoria Watson, John Tjia, et al.In Silico Pharmacology|December 16, 2014
Use of a physiologically-based pharmacokinetic model to simulate artemether dose adjustment for overcoming the drug-drug interaction with efavirenzMarco Siccardi, Adeniyi Olagunju, Kay Seden, et al.European Journal of Drug Metabolism and Pharmacokinetics|September 30, 2022
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic ModellingHannah Kinvig, Nicolas Cottura, Andrew Lloyd, et al.CPT: Pharmacometrics & Systems Pharmacology|November 3, 2021
Physiologically based pharmacokinetic modeling for dose optimization of quinine-phenobarbital coadministration in patients with cerebral malariaTeerachat Sae-Heng, Rajith Kumar Reddy Rajoli, Marco Siccardi, et al.Pharmacogenetics and Genomics|June 21, 2014
CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adultsAdeniyi Olagunju, Alessandro Schipani, Marco Siccardi, et al.Therapeutic Drug Monitoring|May 17, 2014
CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patientsAdeniyi Olagunju, Marco Siccardi, Alieu Amara, et al.Antimicrobial Agents and Chemotherapy|April 25, 2018
Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and ComedicationsFelix Stader, Hannah Kinvig, Manuel Battegay, et al.Journal of Materials Chemistry. B|December 6, 2021
Evaluating the impact of systematic hydrophobic modification of model drugs on the control, stability and loading of lipid-based nanoparticlesCameron Hogarth, Keith Arnold, Andrew McLauchlin, et al.Pageof 13